đź“‹ FDA Reference
ethos aquell hioxifilcon a one-day soft hydrophilic contact lenses 59 water
Plexus Optix
Summary: The ethos aquell hioxifilcon a one-day soft hydrophilic contact lenses are designed for daily wear to correct vision. They are primarily used by optometrists and ophthalmologists for patients requiring vision correction.
FDA Clearance Information
Pathway
510K
Number
K201268 ↗
Decision Date
October 21, 2020
Product Code
LPL
Device Class
Class 2
Evidence
419 studies
The ethos aquell hioxifilcon a lenses were cleared through the FDA 510(k) pathway on October 21, 2020. Manufactured by Plexus Optix, these lenses are classified as Class 2 medical devices.
What It Is
The ethos aquell hioxifilcon a lenses are daily disposable soft contact lenses made from a hydrophilic material with 59% water content. They are designed to provide comfort and clear vision for individuals with refractive errors such as myopia or hyperopia. The lenses work by sitting on the cornea, correcting the path of light entering the eye to improve focus.
Clinical Applications
These contact lenses are commonly used in outpatient settings by optometrists and ophthalmologists. They are suitable for patients who prefer the convenience of daily disposable lenses, reducing the risk of infection associated with extended wear. The lenses are ideal for individuals with active lifestyles or those who experience discomfort with other types of contact lenses.
Indications for Use
The FDA indications suggest these lenses are intended for daily wear to correct refractive errors like nearsightedness or farsightedness. They are suitable for patients seeking a comfortable and convenient vision correction option.
Practical Considerations
The lenses are available in a range of powers to accommodate different levels of vision correction. They are designed for single-day use, eliminating the need for cleaning and storage. Clinicians should ensure proper fitting and educate patients on correct insertion and removal techniques.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →
PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →
PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →
PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →
PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →
PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →
PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →
PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →
PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What is ethos aquell hioxifilcon a used for?
These lenses are used for correcting refractive errors such as myopia and hyperopia in patients who prefer daily disposable contact lenses.
What specialties typically use this device?
Optometrists and ophthalmologists typically use these lenses in their practice for vision correction.
What are the FDA-cleared indications?
The lenses are indicated for daily wear to correct refractive errors like nearsightedness or farsightedness.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.